Cytosorbents Investor Relations Material
Latest events
Q2 2025
Cytosorbents
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cytosorbents Corporation
Access all reports
Cytosorbents Corporation is a medical device company specializing in blood purification technologies. The company develops and markets the CytoSorb adsorber, a device designed to reduce harmful substances such as cytokines, toxins, and metabolic waste from the bloodstream. These technologies are used in critical care and cardiac surgery applications to manage conditions like sepsis, inflammation, and organ failure. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Cytosorbents Corporation
Q1 2025
Cytosorbents Corporation
Investor Presentation
Cytosorbents Corporation
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
CTSO
Country
🇺🇸 United States